Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
Clinical trial NCT04788511 · COMPLETED
Trial details
- NCT number
- NCT04788511
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-16
- Primary completion
- 2023-04-18
- Enrollment
- 529
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.